|
Attention Investors |
|
|
|
|
|
|
|
|
|
|
|
|
|
Your results on : Equity | News | Company-News |
|
|
|
Sun Pharma proposes to acquire Taro |
Share Back |
(27 May 2023) |
Sun Pharmaceuticals Industries on 26 May 2023 has issued a letter to the Board of Directors of Taro Pharmaceutical Industries, Israel (Taro) with a proposal containing a non-binding indication of interest to acquire all of the outstanding ordinary shares in Taro, other than any shares already held by the Company or its affiliates (For a purchase price of $38 per ordinary share) (Proposed Transaction).
The Proposed Transaction to be consummated in the form of a reverse triangular merger under the Israeli Companies Law, 1999 (ICL) and practice. In this context, Purchaser shall form a wholly owned subsidiary (SPV), which shall enter into a merger agreement with Taro, with
the SPV merging with and into Taro and Taro surviving the merger transaction. Consequently, Taro shall become a wholly owned subsidiary of Purchaser and be de-listed from NYSE. |
Top |
|
|
|
|
|
|
|
X |
Filing complaints on SCORES |
Easy & Quick |
|
› |
Register on SCORES Portal |
› |
Mandatory details for filing complaints on SCORES
Name |
PAN |
Address |
Mobile No. |
Email ID |
|
› |
Benefits: |
|
|
|
|